Flu or COVID-19? Major differences you need to know
Tuesday, 15 September 2020 As the COVID-19 cases continue to rise, comparisons between influenza (flu) and COVID-19 symptoms have been drawn. Flu and COVID-19 share many characteristics, but there are some key differences between the two. With the flu season fast approaching, have you ever wondered the difference between flu and COVID-19 virus? Similarities between influenza and COVID-19 Influenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different viruses. COVID-19 is caused by infection with a new coronavirus (called SARS-CoV-2) and flu is caused by infection with influenza viruses. Also read Coronavirus was created in Wuhan lab, Chinese virologist Li-Meng Yan exposes China...
From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the...
A new open source, a cloud-based tool called IDseq makes it possible to rapidly detect, identify, and track emerging pathogens such as SARS-CoV-2. This tool can identify pathogens before there is an available complete genome sequence; thus, it can be used for current infectious disease outbreaks and also for emerging ones. This will substantially aid in preventing future pandemics. The study was published in the journalGigaScience. The coronavirus pandemic demonstrates the importance of global infectious disease monitoring. Finding the cause of an infectious disease outbreak is challenging, especially if it stems from a previously unknown pathogen. IDseq, an open-source, cloud-based metagenomic analysis platform, identifies both novel and existing disease-causing pathogens from a given sample - be it a human, animal, or parasite - to provide an actionable report of what is happening on the ground in labs and clinics anywhere in the world. The new user-friendly IDseq software is open source and freely available to the global health community, reducing the barrier of entry to metagenomics.
Over one million people have now died from coronavirus worldwide. This milestone comes almost nine months after the first Covid-19 death was recorded in Wuhan, China. Data captured by Johns Hopkins University shows that the USA, Brazil and India make up for nearly half the global coronavirus deaths. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
A method for fast, cheap, yet accurate testing for COVID-19 infection has been developed by a team of researchers. The method simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics. This makes the method particularly attractive for places and situations with limited resources. It is equally interesting for repeated testing and for moving resources from expensive diagnostics to other parts of the care chain. The study led by researchers at the Karolinska Institutet was published in the journal Nature Communications."We started working on the issue of developing a readily available testing method as soon as we saw the developments in Asia and southern Europe, and before the situation reached crisis point in Sweden," says principal investigator Bjorn Reinius, research leader at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet. "Our method was effectively finished already by the end of April, and we then made all the data freely available online."The spread of the new coronavirus at the end of 2019 in China's Wuhan region quickly escalated into a global pandemic. The relatively high transmission rate and a large number of asymptomatic infections led to a huge, worldwide need for fast, affordable, and effective diagnostic tests that could be performed in clinical as well as non-clinical settings.
Sept. 22 (UPI) -- COVID-19 causes acute kidney injury that can lead to death in some people infected with the virus, a study published Tuesday by the Clinical Journal of the American Society of Nephrology found. In an analysis of nearly 1,400 patients with the new coronavirus in Wuhan, where the pandemic began, 7% of those who required hospital care developed acute kidney injury, the data showed. Advertisement Of those who experienced this complication, 72% died of COVID-19, the researchers said. Among those without kidney damage, 10% died from the virus.
Recovery rate of Nepal's COVID-19 infected patients stood at around 56 percent in an early fortnight of August, while towards the end of the month, it has dipped down to 54, increasing worries and panic for health workers and government. Fatalities attributed to deadly virus crossed 100 mark in mid-August. As month marches to end, it doubled with 14 deaths on Sunday taking the number to 221. It was the month of (mid) May, the Himalayan Nation, buffered in between India and China had recorded its first fatality due to Corona Virus. Nepal recorded a single-day rise of 1221 cases with 14 more fatalities to deadly virus taking toll of infected to 38,561 while a number of recovered ones stands at 20, 822. Till Sunday, a total of 144 Corona infected patients are kept in the Intensive Care Unit whereas 17 are in ventilator throughout the nation. Though some patients underwent Plasma Therapy, 20 of them only have recovered fully till last week, the Health Ministry data showed. With the swift rise in COVID-19 cases, doctors along with other medical workers working on the frontline of the pandemic are facing increased pressure. More than 50 doctors were reported to be infected while working on the front line treating patients whose coronavirus test was not done before being admitted or brought to the hospital. Falling short of beds for COVID-19 infected patients with a decreased rate of recovery, the Government under the leadership of KP Sharma Oli has added up beds in hospitals around nation. In the month of January, Nepal was the first nation in South Asia to confirm the infection in a Wuhan returnee Nepali citizen.